It was reported that the orange hub of a turbo-ject® double lumen minocycline/rifampin over-the-wire power-injectable picc partially separated from the extension tubing.The line was used for infusion of "hl, carrier, valium, and valporate".Consequently, the device had to be removed and replaced.Additional information regarding the patient, device, and event has been requested but is currently unavailable.
|
Investigation ¿ evaluation.It was reported by lurie children¿s hospital, usa that a turbo-ject® double lumen minocycline/rifampin over-the-wire power-injectable picc (rpn: upicds-4.0-ct-nt-abrm-1111; lot: 13768166) experienced a separation at the junction of the orange hub and the extension tube.The device was required by a four-year-old female for medication infusion.The picc was placed in the patient on (b)(6)2021.On (b)(6) 2021, separation between the orange hub and extension tube was noted.As a result, the patient reported to interventional radiology to remove and replaced the picc with an additional, unknown device.No other adverse effects were reported.Reviews of the complaint history, device history record (dhr), instructions for use (ifu), and quality control of the device were conducted during the investigation.The complaint device was not returned; therefore, no physical examinations could be performed.However, a photo was provided by the customer showing partial separation of the orange hub and extension tube.Additionally, a document-based investigation evaluation was performed.A review of the device master record (dmr) concluded that sufficient inspection activities are in place to identify this failure mode prior to distribution.A review of the design history file (dhf) showed that this device is both safe and effective for its intended use.A review of the device history record (dhr) for the reported complaint device lot (13768166) and the related subassembly lots revealed no non-conformances relevant to the failure mode.A database search found one additional complaint associated with this lot; this complaint was from the same facility and for the same reported failure.While there are additional complaints on this lot, there is currently no evidence of manufacturing deficiencies.Based on the available information, cook has concluded that there is no evidence suggesting nonconforming product exists either in house or in field.Cook also reviewed product labeling.The instructions for use (ifu) document t_upicabrmtt_rev1 [cook spectrum turbo-ject peripherally inserted central venous catheters with micropuncture peel-away introducers] is packaged with this device.The product ifu states the following in consideration of the reported failure mode: "intended use: the cook spectrum turbo-ject peripherally inserted central venous catheter (picc) sets are indicated for short- or long-term use for venous pressure monitoring, blood sampling, administration of drugs and fluids, and for use with power injectors for delivery of contrast in ct studies¿the maximum pressure limit setting for power injectors used with the spectrum turbo-ject picc may not exceed 325 psi and the flow rate may not exceed the maximum flow rate indicated, as shown on the following table.Warnings: ¿ the safe and effective use of spectrum turbo-ject picc lines with power injector pressures set above 325 psi has not been established.¿ do not power inject if maximum injection rate cannot be verified to meet limit printed on catheter hub or extension tube.¿ to safely use catheters with a power injector, the technician/health care professional must verify: ¿ prior to use that the maximum pressure limit is set at or below 325 psi and that the maximum flow rate is at or below that which is listed on the catheter.Precautions: ¿ if lumen flow is impeded, do not force injection or withdrawal of fluids.Catheter maintenance: if catheter is not to be used immediately, its lumen should be maintained by continuous saline or heparinized saline drip or locked with heparinized saline solution.How supplied: upon removal from package, inspect the product to ensure no damage has occurred." based on the available information, no product returned, and the results of the investigation, the root cause of this event is related to inadequate flexural strength in a previous hub design change.Appropriate measures have been taken to address this failure mode.A capa was previously opened to further investigate this failure mode.Per the quality engineering risk assessment no further action is required.The appropriate personnel have been notified.Cook will continue to monitor for similar complaints.This report is required by the fda under 21 cfr part 803 and is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement contained herein is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, nor that any cook device caused, contributed to, or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|